Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
28 Jun 2025
Europe Urged to Improve Newborn Biliary Atresia Screening
Biliary atresia is the most common surgical cause of cholestatic jaundice in infants and the leading reason for paediatric liver transplants
28 Jun 2025
Saliva Testing Identifies Early Risk for Cancer and Chronic Diseases
Saliva-based DNA markers could predict cancer, heart disease, and more—offering a non-invasive future for early diagnosis.
28 Jun 2025
MVA-BN Vaccine Offers Safe Mpox Protection in At-Risk Groups
A German multicentre study shows MVA-BN vaccination is safe and moderately effective in preventing mpox, especially in HIV-negative individuals.
28 Jun 2025
Dupilumab Linked to Increased Psoriasis Risk in Atopic Dermatitis
Given dupilumab’s well-documented benefits in controlling moderate to severe AD, clinicians are advised to weigh this potential risk carefully against its therapeutic advantages.
27 Jun 2025
Widespread Ignorance of Alcohol’s Cancer Risk
Despite alcohol being a leading preventable cause of cancer in the United States, public awareness of its cancer risk remains strikingly low, according to a new study.
6
Mins
27 Jun 2025
Critical Management of Neurocysticercosis with Hydrocephalus
Neurocysticercosis, a parasitic brain infection caused by the larvae of Taenia solium that leads to cysts in the central nervous system…
27 Jun 2025
Minimally Invasive Treatment for Benign Prostatic Hyperplasia
Importantly, 30% mean reductions in prostate volume were sustained up to 18 months post-procedure.
Sun Pharma appoints Richard Ascroft as North American CEO
Ascroft brings more than 30 years of industry experience, including senior roles at Takeda Pharmaceuticals.
27 Jun 2025
Can Microbiome-Guided Therapy Improve Cystic Fibrosis Outcomes?
A new international trial has investigated the safety and efficacy of tailoring antibiotic treatment for cystic fibrosis exacerbations based on sputum microbiome analysis.
27 Jun 2025
Combined Therapy for Allergic Rhinitis Shows Superior Results
The combination therapy demonstrated a significantly higher response rate (98.28%) compared to loratadine alone (87.93%).
←
1
2
3
4
5
…
1,155
1,156
1,157
→
We’ve noticed you’re accessing
from
North/South America.
View
View